Evidence map›Paper›PMID 12149437›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice.

Vijay K Yechoor, Mary-Elizabeth Patti, Robert Saccone, C Ronald Kahn

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vijay K YechoorJoslin Diabetes Center and Department of Medicine, Harvard Medical School, One Joslin Place, Boston, MA 02215, USA.
Mary-Elizabeth Patti
Robert Saccone
C Ronald Kahn

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
GENE EXPRESSION IN DIABETES BY SUBTRACTIVE CLONINGR01DK045935 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1993 to 2003
$2.8M
NIDDK NIH HHS DK33201NIDDK NIH HHS DK36836-15NIDDK NIH HHS DK45935NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK033201NIDDK NIH HHS R01 DK045935
6 · The paper itself

Abstract

Metabolic abnormalities underlying diabetes are primarily the result of the lack of adequate insulin action and the associated changes in protein phosphorylation and gene expression. To define the full set of alterations in gene expression in skeletal muscle caused by diabetes and the loss of insulin action, we have used Affymetrix oligonucleotide microarrays and streptozotocin-diabetic mice. Of the genes studied, 235 were identified as changed in diabetes, with 129 genes up-regulated and 106 down-regulated. Analysis revealed a coordinated regulation at key steps in glucose and lipid metabolism, mitochondrial electron transport, transcriptional regulation, and protein trafficking. mRNAs for all of the enzymes of the fatty acid beta-oxidation pathway were increased, whereas those for GLUT4, hexokinase II, the E1 component of the pyruvate dehydrogenase complex, and subunits of all four complexes of the mitochondrial electron transport chain were all coordinately down-regulated. Only about half of the alterations in gene expression in diabetic mice could be corrected toward normal after 3 days of insulin treatment and euglycemia. These data point to as of yet undefined mechanisms for highly coordinated regulation of gene expression by insulin and potential new targets for therapy of diabetes mellitus.

Indexed as

Carrier ProteinsEnergy MetabolismGene ExpressionIntracellular Signaling Peptides and ProteinsAdenosine TriphosphatasesAnimalsBiological TransportCarbohydrate MetabolismCysteine EndopeptidasesDiabetes Mellitus, ExperimentalElectron Transport Complex IElectron Transport Complex IIElectron Transport Complex IIIElectron Transport Complex IVGene Expression ProfilingGlucosidasesAdenosine TriphosphatasesCarrier ProteinsCysteine EndopeptidasesElectron Transport Complex IElectron Transport Complex IIElectron Transport Complex IIIElectron Transport Complex IVGlucosidasesIntracellular Signaling Peptides and ProteinsMembrane ProteinsMitochondrial Proton-Translocating ATPasesMultienzyme ComplexesMyristoylated Alanine-Rich C Kinase SubstrateNADH, NADPH Oxidoreductasesoligomycin sensitivity-conferring proteinOxidoreductasesPhosphoproteinsPrkcsh protein, mouseProcollagenProteasome Endopeptidase ComplexStreptozocinSuccinate Dehydrogenase

Identifiers

PMID12149437
PMCPMC124982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.